Augplat 250mcg (Romiplostim Injection) 250mcg

Augplat 250mcg is a prescription subcutaneous injection containing the active ingredient Romiplostim. It belongs to a class of medications known as thrombopoietin (TPO) receptor agonists. This therapeutic agent is designed to stimulate platelet production in the bone marrow to help manage severe bleeding risks associated with low platelet counts.

Strength

250mcg

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Augplat 250mcg is indicated for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to other treatments, such as corticosteroids, immunoglobulins, or splenectomy. It works by binding to and activating the TPO receptor, which stimulates megakaryopoiesis and increases overall platelet production.

Side Effects

Common side effects of Augplat 250mcg include headaches, joint pain, muscle aches, dizziness, difficulty sleeping, and pain in the extremities. Serious potential risks include an increased risk of blood clots (thromboembolism), worsening of low platelets after stopping the medication, and changes in bone marrow structure. Patients should seek immediate medical attention if they experience sudden swelling, pain in the limbs, or shortness of breath.

Precautions & Warnings

Before starting treatment with Augplat 250mcg, patients must inform their healthcare provider of any history of blood clots, liver disease, kidney disorders, or blood cancers. Regular blood monitoring, specifically complete blood counts (CBC) to check platelet levels, is mandatory during therapy. The safety of Romiplostim during pregnancy or breastfeeding has not been fully established, and it should only be used under strict medical guidance.

Avoid Interactions

Augplat 250mcg may interact with other medications that influence platelet function or increase bleeding risks, including anticoagulants, antiplatelet agents, and nonsteroidal anti-inflammatory drugs (NSAIDs). Combining Romiplostim with other treatments for immune thrombocytopenia (ITP) may require careful dose adjustments. Always provide your healthcare team with a complete list of all prescription drugs, over-the-counter medications, and supplements you are taking.

Frequently Asked Questions

Augplat 250mcg is primarily prescribed to treat low platelet counts in adult patients with chronic immune thrombocytopenia (ITP) who have not responded adequately to other treatments like corticosteroids or immunoglobulins.

Augplat 250mcg is administered as a subcutaneous injection, typically given once weekly by a healthcare professional. The dosage is adjusted individually based on the patient's platelet count.

Common side effects of Romiplostim (Augplat) include headache, joint pain, muscle aches, dizziness, insomnia, and pain in the arms or legs. If you experience severe symptoms or signs of blood clots, contact your doctor immediately.

No, Augplat is not a cure for chronic ITP. It is a long-term management therapy designed to stimulate platelet production and maintain platelet counts at a safer level to reduce the risk of bleeding.

Patients receiving Augplat require regular complete blood count (CBC) tests, usually weekly before starting and during dose adjustments, and then monthly once a stable dose is established, to monitor platelet levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.